Crizotinib/lorlatinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1941卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32418-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[41] Crizotinib/everolimus interactionVarious toxicities: case report
Reactions Weekly, 2020, 1822 (1) : 105 - 105
[42] CrizotinibDevelopment of crizotinib resistance: case report.
Reactions Weekly, 2020, 1820 (1) : 113 - 113
[43] Ceritinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2018, 1702 (1) : 73 - 73
[44] Cisplatin/crizotinib/pemetrexedTreatment failure: case report
Reactions Weekly, 2023, 1950 (1) : 124 - 124
[45] Crizotinib/erlotinibSkin and visual toxicity: case report
Reactions Weekly, 2015, 1544 (1) : 82 - 82
[46] Alectinib/crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2020, 1798 (1) : 22 - 22
[47] Crizotinib/pemetrexedColitis, malaise and nausea: case report
Reactions Weekly, 2017, 1658 (1) : 148 - 148
[48] Crizotinib/enoxaparin sodiumVarious toxicities: case report
Reactions Weekly, 2012, 1394 (1) : 17 - 17
[49] Cisplatin/crizotinib/pemetrexedLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1941 (1) : 142 - 142
[50] Crizotinib/alectinibExacerbation of renal dysfunction: case report
Reactions Weekly, 2017, 1664 (1) : 98 - 98

← 1 2 3 4 5 →